Ignite Creation Date:
2024-05-06 @ 1:15 PM
Last Modification Date:
2024-10-26 @ 1:11 PM
Study NCT ID:
NCT03970837
Status:
TERMINATED
Last Update Posted:
2023-11-30
First Post:
2019-05-16
Brief Title:
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic csBiologic b Disease Modifying Anti-rheumatic Drugs DMARDs
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-05
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-18
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-16
First Submit QC Date:
May 29 2019
Study First Post Date:
2019-06-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-11-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2022-08-05
Disp First Submit QC Date:
November 10 2023
Disp First Post Date:
2023-11-30
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-11-10
Last Update Post Date:
2023-11-30
Last Update Post Date Type:
ACTUAL